Abstract Intradialytic hypotension (IDH) is a frequent and serious complication of chronic haemodialysis, linked to adverse long-term outcomes including increased cardiovascular and all-cause mortality. IDH is the end result of the interaction between ultrafiltration rate (UFR), cardiac output and arteriolar tone.
Intradialytic hypotension (IDH), a common complication of ultrafiltration during hemodialysis therapy, is associated with high mortality and morbidity. IDH, defined as a nadir systolic blood pressure of less than 90 mmHg on more than 30% of treatments, is a relevant definition and is correlated with mortality.
Abstract Background Intradialytic hypotension (IDH) is an acknowledged problem within haemodialysis care settings.Whilst the causes are recognised to be multifactorial, likewise, no one solution.Acute intradialytic hypotension observed in 20-33% of hemodialysis patients is a very common complication of this kind of renal replacement therapy. The study was performed in 40 uremic patients, treated with hemodialysis at the Nephrology Clinic of the University Hospital in Cracow. In every patient, 3 model dialysis sessions were carried out. Total fluid removal was the same during every.INTRODUCTION: Intradialytic hypotension (IDH) is a common complication in end-stage renal disease patients on hemodialysis (HD). It has been documented that several factors contribute to IDH. However, the relationship between serum electrolytes and the occurrence of IDH remains unclear. Our study aims to investigate the role of serum magnesium (Mg) for the risk of IDH in maintenance HD.
Intradialytic hypotension (IDH) is a global public health problem. A rising number of IDH sufferers resort to Chinese patent medicine, Shengmai Injection (SMI) in China. The objectives of present study are to assess the effectiveness and safety of SMI as an adjunct therapy for IDH. A systematic search of 6 medical databases was performed up to December 2011.Read More
Intradialytic hypotension (IDH) is a global public health problem. A rising number of IDH sufferers resort to Chinese patent medicine, Shengmai Injection (SMI) in China. The objectives of present study are to assess the effectiveness and safety of SMI as an adjunct therapy for IDH.Read More
Patients with CKD and regular hemodialysis who experience moderate or severe intradialytic hypotension have significantly higher prevalence of myocardial ischemia and stress induced myocardial dysfunction than those who experience no or mild intradialytic hypotension. It is well established that there exists a relationship between pre- to postdialysis changes in BP and mortality. Both.Read More
Intradialytic hypotension is mainly induced by the removal of extracellular sodium during dialysis, which impairs intravascular fluid refilling and reduces blood volume. To counter this complication we tested a new kind of profiled hemodialysis (PHD) consisting of the intradialytic modulation of dialysate sodium concentration according to individual profiles set up using a new mathematical.Read More
The research article discussed using isothermal dialysis to control the intradialytic hypotension (IDH) and patient comfort during hemodialysis. IDH has been responsible for early termination of dialysis treatment, which has resulted in patients receiving inadequate treatment, metabolic waste buildup and an increase in fluid volume overload causing further complications (Jianjun, Baird, Van.Read More
I demonstrated a 20-30% prevalence of intradialytic symptoms and hypotension in children during conventional, 4 hour haemodialysis (HD) sessions. The declining blood pressure (BP) was originally believed to be caused by ultrafiltration (UF) and priming of the HD circuit due to loss of fluid from the intravascular space. However data, largely in adults, challenged this hypothesis leading to a.Read More
Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Critical Care, Nov 2014 Jonathan A Silversides, Ruxandra Pinto, Rottem Kuint, Ron Wald, Michelle A Hladunewich, Stephen E.Read More
Intradialytic hypotension remains the most frequent complication associated with routine outpatient hemodialysis. Although increasing dialysis frequency and also lengthening dialysis session duration can reduce the risk of intradialytic hypotension, in practice, these options are limited to a small minority of dialysis patients. To help reduce intradialytic hypotension, a number of.Read More
Intradialytic hypotension in haemodiafiltration and conventional haemodialysis: Authors: Debattista, Pauline: Keywords: Hemodialysis Chronic renal failure -- Treatment Hypotension Blood pressure: Issue Date: 2016: Abstract: Background: The fundamental objective of all dialysis therapies is the efficient cleansing of the blood from all uraemic toxins and fluid overload. The most frequent.Read More
In sharp contrast, earlier and recent interventional studies have documented that feeding during the hemodialysis treatment provokes a rapid postprandial decline in blood pressure and raises the incidence of symptomatic intradialytic hypotension. Furthermore, other studies have shown that postprandial redistribution in intravascular volume and enhanced blood supply to the gastrointestinal.Read More